Northeast Bank (NBN) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Conference Call February 7, 2025 10:00 AM ETCompany ParticipantsRichard Wayne - President and Chief ...
Becton, Dickinson and Company (BDX) Q1 2025 Earnings Call Transcript
At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at 1-800-839-2486 for domestic calls and area ...
Hosted on MSN6d
FactChecking RFK Jr.’s Other Health Claims During HHS Confirmation Hearings
Poland was not available for an interview, but he previously told us for a 2021 ... FDA amended its authorization for ...
aad.org6d
Cutaneous T-cell lymphoma: Diagnosis & treatment
The U.S. Food and Drug Administration (FDA) has approved this ... An update 2021.” Hematol Oncol. 2021 Jun;39 Suppl 1:46-51. Medline Plus (National Library of Medicine) “Mogamulizumab-kpkc injection.” ...
FDA approves new genetic disorder drug
The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of noncancerous tumors on ...
FDA approves Roche’s Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy (SMA)
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be ...
SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...
The FDA just approved a new painkiller. Is it too good to be true?
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
Monthly Prescribing Reference7d
January 2025: Notable Drug Approvals
Ozempic Approval Expanded to Include T2D Patients ... patients as young as 1 year old experiencing fat malabsorption. FDA Clears Digestive Enzyme Cartridge RELiZORB for Kids as Young as 1 Year ...
U.S. FDA Grants Orphan Drug Designation to Ariceum Therapeutics' Proprietary Radiopharmaceutical Cancer Therapy
Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the U.S. Food ...
Sydney Morning Herald7d
A small team of Australian scientists won a rare drug approval – and upended the pharma system
MDGH’s high-risk plan was to get investors to gamble that a small team of scientists working as a not-for-profit could get a drug for a neglected disease approved by the FDA. If the approval ...
MedPage Today6d
FDA OKs New Antibiotic Combo for Complicated Intra-Abdominal Infections
monobactam/beta-lactamase inhibitor combination antibiotic to receive FDA approval. "The continued evolution of antimicrobial resistance among Gram-negative bacteria has left some patients with ...